Also known as: CRC per le Malattie Rare Aldo e Cele Daccò
Highest phase reached
Phase 2
First clinical trial
Last known activity
Sep 30, 2018
No events for the selected filters.
Phase 2 (2 own, 0 via acquisition)
Studied for